Liver Medicine Trials

  • 01/07/2013

    NOBLES

    Novel Biomarkers of LivEr FibrosiS Study

    View Trial
  • 31/12/2019

    Use of venesected blood from patients with haemochromatosis to isolate and culture lmmune cells

    View Trial
  • 30/08/2019

    Expression and function of immune regulatory proteins in human liver

    View Trial
  • 31/01/2017

    GS-US-248-0123

    A Long Term Follow-up Registry Study of Subjects Who Did Not Achieve Sustained Virologic Response in Gilead-Sponsored Trials in Subjects with Chronic Hepatitis C Infection

    View Trial
  • 01/03/2022

    AN OBSERVER-BLIND RANDOMIZED STUDY WITH AN OPEN-LABEL PART TO EVALUATE THE SAFETY TOLERABILITY PHARMACOKINETICS AND PHARMACODYNAMICS OF SUBCUTANEOUS ADMINISTRATION OF RO7191863 WITH MULTIPLE DOSES AND DIFFERENT REGIMENS IN VIROLOGICALLY SUPPRESSED PATIENTS WITH CHRONIC HEPATITIS B INFECTION

    View Trial
  • 30/06/2021

    A first-in-human double-blind randomized placebo-controlled Phase 1 study to evaluate the safety tolerability reactogenicity and immunogenicity of JNJ-64300535 a DNA vaccine administered by intramuscular injection and electroporation in subject with chronic Hepatitis B who are virologically suppressed and on stable nucleos(t)ide therapy

    View Trial
  • 01/05/2016

    Immune responses in liver cancer following treatment

    View Trial
  • Development of a stratified care pathway for Primary Biliary Cholangitis (PBC): patient and physician perspectives on management in primary care

    View Trial
  • 01/04/2017

    CALM

    LiverMultiscan with MRI- Replacing liver biopsy

    View Trial